Published in Hepatitis Weekly, December 13th, 1999
P. Fabris and colleagues performed a study to with the aim of testing the hypothesis that ketoprofen may increase the rate of response to alpha-interferon of chronic hepatitis C patients ("Interferon alfa-2b Alone or in Combination with Ketoprofen As Treatment for Interferon-Naive Chronic Hepatitis C Patients," Alimentary Pharmacology & Therapeutics,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly